Exelixis
EXEL
#1647
Rank
โ‚น1.271 T
Marketcap
โ‚น5,059
Share price
-5.25%
Change (1 day)
55.61%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company